Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative ulinastatin for endothelial glycocalyx protection during Whipple procedure
ChiCTR1900024004Phase 4Completed
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of ulinastatin in pancreatic cancer (PC) (2 arms), sponsored by Beijing Chaoyang Hospital. Primary endpoints: plasma albumin, C-reactive protein and 5 more. Started Jan 2015; status: completed.
02
Drugs
ulinastatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on ChiCTR1900024004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024004.